IQVIA Holdings Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de IQVIA Holdings de 13.8% y 5.3% por año respectivamente. Se prevé que el BPA crezca en un 13.5% al año. Se espera que la rentabilidad financiera sea de 31.4% en 3 años.
Información clave
13.8%
Tasa de crecimiento de los beneficios
13.5%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Life Sciences | 18.5% |
| Tasa de crecimiento de los ingresos | 5.3% |
| Rentabilidad financiera futura | 31.4% |
| Cobertura de analistas | Good |
| Última actualización | 15 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?
Nov 14
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?
Oct 21IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't
Sep 22IQVIA Holdings Inc. (NYSE:IQV) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 08Reiterating Buy On IQVIA After Q2 Earnings
Aug 20With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case
Aug 11Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?
Jul 30These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well
Jul 18An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued
Jun 04IQVIA: Long-Term Compounder Throwing Off Free Cash Flow
May 27Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?
Apr 24Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?
Apr 11IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up
Mar 27Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors
Mar 14IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024
Feb 22Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?
Jan 23Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings
Dec 24We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt
Dec 08Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?
Nov 23IQVIA Q3: TAS Segment Remains The Problem Child
Nov 21IQVIA: I Would Stay Away Until Debt Issues Are Resolved
Nov 12Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?
Oct 08IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term
Sep 07Is IQVIA Holdings (NYSE:IQV) A Risky Investment?
Sep 04Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching
Aug 11IQVIA Holdings Q2: Breaking Ground And Beating Expectations
Aug 03IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price
Jun 27IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet
Jun 05IQVIA Holdings: A Possible Beat And Raise Scenario In The Works
May 23What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?
May 04A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)
Mar 19Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?
Mar 05Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today
Feb 12IQVIA Q4 2022 Earnings Preview
Feb 09When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?
Jan 29IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader
Jan 24We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt
Nov 09IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth
Nov 02IQVIA Q3 2022 Earnings Preview
Oct 25Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?
Oct 02IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)
Sep 19With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case
Aug 22GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US
Aug 11We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt
Aug 08IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same
Jul 28Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?
Jul 26IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance
Jul 21Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 17,179 | 1,793 | 2,471 | 3,082 | 17 |
| 12/31/2025 | 16,243 | 1,536 | 2,148 | 2,735 | 22 |
| 12/31/2024 | 15,387 | 1,338 | 1,882 | 2,478 | 18 |
| 9/30/2024 | 15,315 | 1,405 | 1,961 | 2,578 | N/A |
| 6/30/2024 | 15,155 | 1,423 | 1,827 | 2,440 | N/A |
| 3/31/2024 | 15,069 | 1,357 | 1,624 | 2,254 | N/A |
| 12/31/2023 | 14,984 | 1,358 | 1,500 | 2,149 | N/A |
| 9/30/2023 | 14,855 | 1,116 | 1,321 | 1,962 | N/A |
| 6/30/2023 | 14,681 | 1,096 | 1,582 | 2,242 | N/A |
| 3/31/2023 | 14,494 | 1,055 | 1,508 | 2,169 | N/A |
| 12/31/2022 | 14,410 | 1,091 | 1,586 | 2,260 | N/A |
| 9/30/2022 | 14,307 | 1,182 | 1,705 | 2,392 | N/A |
| 6/30/2022 | 14,136 | 1,160 | 1,689 | 2,373 | N/A |
| 3/31/2022 | 14,033 | 1,079 | 1,915 | 2,583 | N/A |
| 12/31/2021 | 13,874 | 966 | 2,302 | 2,942 | N/A |
| 9/30/2021 | 13,536 | 767 | 2,368 | 3,000 | N/A |
| 6/30/2021 | 12,931 | 607 | 2,103 | 2,730 | N/A |
| 3/31/2021 | 12,014 | 409 | 2,039 | 2,663 | N/A |
| 12/31/2020 | 11,359 | 279 | 1,343 | 1,959 | N/A |
| 9/30/2020 | 10,956 | 176 | 1,215 | 1,792 | N/A |
| 6/30/2020 | 10,939 | 132 | 979 | 1,548 | N/A |
| 3/31/2020 | 11,158 | 215 | 885 | 1,467 | N/A |
| 12/31/2019 | 11,088 | 191 | 835 | 1,417 | N/A |
| 9/30/2019 | 10,881 | 244 | 668 | 1,251 | N/A |
| 6/30/2019 | 10,706 | 247 | 708 | 1,265 | N/A |
| 3/31/2019 | 10,533 | 248 | 673 | 1,185 | N/A |
| 12/31/2018 | 10,412 | 259 | 795 | 1,254 | N/A |
| 9/30/2018 | 10,245 | 1,217 | 647 | 1,070 | N/A |
| 6/30/2018 | 10,117 | 1,245 | N/A | 1,162 | N/A |
| 3/31/2018 | 9,905 | 1,246 | N/A | 1,096 | N/A |
| 12/31/2017 | 9,702 | 1,277 | N/A | 970 | N/A |
| 9/30/2017 | 9,133 | 72 | N/A | 1,184 | N/A |
| 6/30/2017 | 7,804 | 84 | N/A | 1,008 | N/A |
| 3/31/2017 | 6,616 | 108 | N/A | 804 | N/A |
| 12/31/2016 | 6,815 | 72 | N/A | 860 | N/A |
| 9/30/2016 | 4,540 | 397 | N/A | 620 | N/A |
| 6/30/2016 | 4,497 | 409 | N/A | 643 | N/A |
| 3/31/2016 | 4,404 | 408 | N/A | 652 | N/A |
| 12/31/2015 | 4,326 | 387 | N/A | 476 | N/A |
| 9/30/2015 | 4,262 | 371 | N/A | 525 | N/A |
| 6/30/2015 | 4,229 | 352 | N/A | 379 | N/A |
| 3/31/2015 | 4,191 | 353 | N/A | 396 | N/A |
| 12/31/2014 | 4,165 | 357 | N/A | 433 | N/A |
| 9/30/2014 | 4,106 | 341 | N/A | 391 | N/A |
| 6/30/2014 | 3,977 | 315 | N/A | 431 | N/A |
| 3/31/2014 | 3,886 | 268 | N/A | 386 | N/A |
| 12/31/2013 | 3,808 | 227 | N/A | 393 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (13.8% al año) de IQV es superior a la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (13.8% al año) de IQV crezcan menos que el mercado US (15.3% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de IQV crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (5.3% al año) de IQV crezcan más despacio que el mercado de US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.3% al año) de IQV crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de IQV sea alta dentro de 3 años (31.4%)